240 related articles for article (PubMed ID: 32095940)
21. Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling.
Ricklefs FL; Fritzsche F; Winkler B; Meissner B; Dührsen L; Westphal M; Rutkowski S; Martens T; Schüller U
Childs Nerv Syst; 2019 Jun; 35(6):1029-1033. PubMed ID: 30796558
[TBL] [Abstract][Full Text] [Related]
22. Signaling pathway and molecular subgroups of medulloblastoma.
Li KK; Lau KM; Ng HK
Int J Clin Exp Pathol; 2013; 6(7):1211-22. PubMed ID: 23826403
[TBL] [Abstract][Full Text] [Related]
23. [Medulloblastoma. Pathology].
Siegfried A; Delisle MB
Neurochirurgie; 2021 Feb; 67(1):28-38. PubMed ID: 29703584
[TBL] [Abstract][Full Text] [Related]
24. Histological subtype of medulloblastoma frequently changes upon recurrence.
Pöschl J; Koch A; Schüller U
Acta Neuropathol; 2015 Mar; 129(3):459-61. PubMed ID: 25662941
[No Abstract] [Full Text] [Related]
25. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
Liu X; Ding C; Tan W; Zhang A
Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
[TBL] [Abstract][Full Text] [Related]
26. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
27. Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles.
Korshunov A; Sahm F; Okonechnikov K; Ryzhova M; Stichel D; Schrimpf D; Casalini B; Sievers P; Meyer J; Zheludkova O; Golanov A; Lichter P; Jones DTW; Pfister SM; Kool M; von Deimling A
Acta Neuropathol; 2019 Jun; 137(6):1003-1015. PubMed ID: 30826918
[TBL] [Abstract][Full Text] [Related]
28. The molecular biology of medulloblastoma metastasis.
Van Ommeren R; Garzia L; Holgado BL; Ramaswamy V; Taylor MD
Brain Pathol; 2020 May; 30(3):691-702. PubMed ID: 31883407
[TBL] [Abstract][Full Text] [Related]
29. The role of chromatin remodeling in medulloblastoma.
Jones DT; Northcott PA; Kool M; Pfister SM
Brain Pathol; 2013 Mar; 23(2):193-9. PubMed ID: 23432644
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
[TBL] [Abstract][Full Text] [Related]
32. CTGF expression is indicative of better survival rates in patients with medulloblastoma.
Cruzeiro GAV; Lira RCP; de Almeida Magalhães T; Scrideli CA; Valera ET; Baumgartner M; Tone LG
Cancer Gene Ther; 2020 May; 27(5):378-382. PubMed ID: 31073205
[TBL] [Abstract][Full Text] [Related]
33. Development and cancer of the cerebellum.
Hatten ME; Roussel MF
Trends Neurosci; 2011 Mar; 34(3):134-42. PubMed ID: 21315459
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity and tumoral origin of medulloblastoma in the single-cell era.
Sheng H; Li H; Zeng H; Zhang B; Lu Y; Liu X; Xu Z; Zhang J; Zhang L
Oncogene; 2024 Mar; 43(12):839-850. PubMed ID: 38355808
[TBL] [Abstract][Full Text] [Related]
35. Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model.
Presutti D; Ceccarelli M; Micheli L; Papoff G; Santini S; Samperna S; Lalli C; Zentilin L; Ruberti G; Tirone F
PLoS One; 2018; 13(3):e0194206. PubMed ID: 29538458
[TBL] [Abstract][Full Text] [Related]
36. Neuro-oncology: Stability of medulloblastoma subgroups at tumour recurrence.
Grill J; Dufour C
Nat Rev Neurol; 2014 Jan; 10(1):5-6. PubMed ID: 24323052
[No Abstract] [Full Text] [Related]
37. Surgery for recurrent medulloblastoma: A review.
Rolland A; Aquilina K
Neurochirurgie; 2021 Feb; 67(1):69-75. PubMed ID: 31351079
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in medulloblastoma.
Giordana MT; Schiffer P; Schiffer D
Childs Nerv Syst; 1998 Jun; 14(6):256-62. PubMed ID: 9694337
[TBL] [Abstract][Full Text] [Related]
39. Molecular Classification of Medullobastomas by Whole Genome Expression Profiling.
Nosková H; Adamcová S; Knoflíčková LDR; Pavelka Z; Vejmělková K; Zitterbart K; Slabý O; Štěrba J
Klin Onkol; 2019; 32(Supplementum1):171-173. PubMed ID: 31064192
[TBL] [Abstract][Full Text] [Related]
40. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma.
Leal LF; Evangelista AF; de Paula FE; Caravina Almeida G; Carloni AC; Saggioro F; Stavale JN; Malheiros SMF; Mançano B; de Oliveira MA; Luu B; Neder L; Taylor MD; Reis RM
Neuropathology; 2018 Oct; 38(5):475-483. PubMed ID: 30155928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
